stem cells types source uses stem cell cancer what is it, pathways

1. BY
Marwa Mahmoud Khalifa
Amr Elfeky
Ahmed Elmoughazy

2.  Undifferentiated cells
 Able to develop into many different cell
types in the body during early life and
growth.
 Serve as a sort of internal repair system,
dividing essentially without limit to
replenish other cells

4.  Self renewal
 Unspecialized but can give rise to specialized
cells (differentiation)
 In some organs, such as the gut and bone
marrow, stem cells regularly divide. In other
organs, however, such as the pancreas and
the heart, stem cells only divide under
special conditions.

5.  Embryonic stem cells
 Non-embryonic "somatic" or "adult" stem cells.
 Induced pluripotent stem cells (ipscs)

6. differentiate into all possible cell
types.
Examples: zygote formed at egg fertilization
and the first few cells that result from the
division of the zygote.
differentiate into almost all cell
types.
Examples: embryonic stem cells and cells
that are derived from the mesoderm,
endoderm, and ectoderm germ layers.

7. differentiate into a closely related
family of cells.
Examples: hematopoietic (adult) stem cells that can
become red and white blood cells or platelets.
differentiate into a few cells.
Examples: (adult) lymphoid or myeloid stem cells.
only produce cells of their own type, but
have the property of self-renewal required to be
labeled a stem cell.
Examples :(adult) muscle stem cells

9.  Embryonic stem cells are derived from a four- or
five-day-old human embryo that is in the
blastocyst phase of development, fertilized in
vitro then donated for research purposes with
informed consent of the donors.

10.  Human embryonic stem cells (hESCs)
are generated by transferring cells from
a preimplantation-stage embryo into a plastic
laboratory culture dish that contains a nutrient
broth known as culture medium.

11. Embryonic stem cells are considered pluripotent instead
of totipotent because they do not have the ability to
become part of the extra-embryonic membranes or the
placenta.

12.  Adult stem cells supply new cells as an organism grows
and to replace cells that get damaged.
 Adult stem cells are said to be multipotent
Hematopoietic stem cells: give rise to all the types
of blood cells:.
Mesenchymal stem cells: Those from bone
marrow (bone marrow stromal stem cells, skeletal
stem cells) give rise to a variety of cell types: bone cells
(osteoblasts and osteocytes), cartilage cells
(chondrocytes), fat cells (adipocytes), and stromal
cells that support blood formation

13.  Adult stem cells supply new cells as an organism grows
and to replace cells that get damaged.
 Adult stem cells are said to be multipotent
Neural stem cells: in the brain give rise to its three
major cell types: nerve cells (neurons) and two
categories of non-neuronal cells—astrocytes and
oligodendrocytes.
Epithelial stem cells: in the lining of the digestive
tract in deep crypts and give rise to : absorptive cells,
goblet cells, Paneth cells, and enteroendocrine cells.

14.  Adult stem cells supply new cells as an organism grows
and to replace cells that get damaged.
 Adult stem cells are said to be multipotent
Skin stem cells: occur in the basal layer of the
epidermis and at the base of hair follicles. The
epidermal stem cells give rise to keratinocytes. The
follicular stem cells can give rise to both the hair
follicle and to the epidermis.

15.  Embryonic stem cells can become all cell types of the
body because they are pluripotent. Adult stem cells are
thought to be limited to differentiating into different
cell types of their tissue of origin.
 Embryonic stem cells can be grown relatively easily in
culture. Adult stem cells are rare in mature tissues, so
isolating these cells from an adult tissue is
challenging, and methods to expand their numbers
in cell culture have not yet been worked out.

16.  Adult cells that have been genetically reprogrammed
to an embryonic stem cell–like state by being forced to
express genes and factors important for maintaining
the defining properties of embryonic stem cells.
 Human iPSCs express stem cell markers and are
capable of generating cells characteristic of all
three germ layers.

17.  Viruses are currently used to introduce the
reprogramming factors into adult cells, and this
process must be carefully controlled and tested before
the technique can lead to useful treatment for
humans.

18.  Once stem cells have been allowed to divide
and propagate in a controlled culture, the
collection of healthy, dividing, and
undifferentiated cells is called a stem cell line.
 Once under control, the stem cells can be
stimulated to specialize as directed by a
researcher - a process known as directed
differentiation.

20. Studies of human embryonic stem cells will
yield information about the complex events
that occur during human development
Some of the most serious medical
conditions, such as cancer and birth defects,
are due to abnormal cell
division and differentiation
Human stem cells are currently being used
to test new drugs. Cancer cell lines, for
example, are used to screen potential anti-
tumor drugs.

21. Generation of cells and tissues that could
be used for cell-based therapies.
Stem cells, directed to differentiate into
specific cell types, offer the possibility of a
renewable source of replacement cells and
tissues to treat diseases including
macular degeneration, spinal cord injury,
stroke, burns, heart disease, diabetes,
osteoarthritis, and rheumatoid arthritis.

22. Stem cells could be used to generate
new organs for use in transplants.
Currently, damaged organs can be
replaced by obtaining healthy organs
from a donor, however donated organs
may be 'rejected' by the body as the
immune system sees it as something
that is foreign.

23. how stem cells can be used to produce retinal pigment epithelium
(RPE) cells that can be used to treat patients with age-related macular
degeneration (AMD).

25.  immortal tumor-initiating cells that can self-
renew and have pluripotent capacity
 can generate tumor cells with different
phenotypes, which results in the growth of the
primary tumor and emergence of new tumors.
 Found in multiple malignancies, including
leukemia and various solid cancers (breast,
lung cancer, colon cancer, prostate cancer,
ovarian cancer, brain cancer, and melanoma).

26. the most common method used to identify
CSCs is fluorescence-activated cell sorting
(FACS) based on cell surface markers or
intracellular molecules.

29. (1) Only a small fraction of the cancer cells within a
tumor have tumorigenic potential when transplanted
into immunodeficient mice.
(2) the CSC subpopulation can be separated from the
other cancer cells by distinctive surface markers;
(3) tumors resulting from the CSCs contain the mixed
tumorigenic and nontumorigenic cells of the original
tumor and

30. (4) the CSC subpopulation can be serially transplanted
through multiple generations, indicating that it is a
self-renewing population” .
Therefore, CSCs are capable of self-renewal and
differentiating into other distinctive cells that make up
the tumor mass.

32. every
cancer cell
is able to
initiate new
tumor
growth
equally
every tumor
contains a
rare
population of
cells termed
CSCs or
cancer
initiating
cells

33.  Physiological stem cells and CSCs depend on their
immediate microenvironment or niche for their
survival and function.
 The cellular and noncellular components of the niche
provide signals that regulate proliferative and self-
renewal signals, thereby helping CSCs to maintain
their undifferentiated state.
 Nonepithelial stromal cells, inflammatory cells and
the vasculature have been proposed as key
components of the niche that support and sustain
CSCs.

35.  ATP-binding cassette (ABC) transporters are
membrane transporters that can pump various
distinct and structurally unrelated small molecules
(such as cytotoxic drugs and dyes) out of cells at the
expense of ATP hydrolysis
 Anti–tumor drugs can be pumped out, thereby
resulting in low intracellular drug concentrations.
Thus, the elevated levels of ABC transporters enable
cancer stem cells to resist current cancer therapies

36. Pathways and elements
involved in the control of self-
renewing and differentiation of
cancer stem cells as well as
normal stem cells include
PI3K/Akt, JAK/STAT, Wnt/β-
catenin, hedgehog, Notch, NF-
κB, ABC superfamily and so on.
Depending on these aberrant
pathways, cancer stem cells
acquire its unique ability to
initiate carcinoma and
promote recurrence after
surgery.

37. JAK/STAT signaling pathway
 The JAK/STAT signaling pathway is activated through
the binding of diverse ligands, such as interleukins,
interferons, hormones, and growth factors, to their
respective receptors.
 JAK/STAT signaling in stem cells has been shown to be
involved in maintaining embryonic stem cell self-
renewal properties, hematopoiesis, and neurogenesis
 Evidence that this pathway is activated aberrantly in
CSCs has been found in stem-like cells isolated from
tumors of the breast, prostate, blood, and glia.

38. JAK/STAT signaling pathway
 Modulation of the JAK/STAT pathway in CSCs has
been shown to enhance or repress the expansion of
these cancer-forming cells in solid tumor model
systems.
 Tumor growth factor-beta (TGF-β) was shown to
regulate the self-renewal and differentiation properties
of glioma-initiating cells derived from patient samples
of glioblastoma multiforme.

39. Hedgehog pathway
 The Hedgehog pathway is essential for the
development and proper patterning of many organs
during embryogenesis, including the nervous system,
skeleton, limbs, lung, heart, and gut, by controlling
cellular proliferation, differentiation, and migration.
 the Hedgehog pathway is largely inactive in most
postnatal tissues except the adult central nervous
system, skin, hair, and teeth.

40. Hedgehog pathway
 The role for Hedgehog signaling in CSC function has been
documented in various cancers, including basal cell
carcinoma (BCC), multiple myeloma, glioblastoma, chronic
myeloid leukemia (CML), and colon cancer.
 Chemical inhibition of the Smoothened protein attenuated
proliferation, stemness maintenance, and self-renewal in
CSCs, suggesting strongly that Hedgehog signaling
promotes these CSC functions in multiple myeloma.
 Treatment of glioma CSCs with a Hedgehog signaling
inhibitor resulted in a decrease in proliferation, survival,
self-renewal, and clonogenicity.

41. Wnt pathway
 Mutations in genes encoding Wnt pathway mediators
are commonplace in many cancers including
medulloblastoma, lymphoma, and leukemia, as well as
breast, gastric, and colorectal cancer (CRC).

42. Notch pathway
 The Notch pathway has been demonstrated to regulate the
properties of tumor cells in many cancers, including
leukemia, glioblastoma, and those of the breast, colon,
pancreas, and lung
 the Notch pathway may be activated in nearly three-
quarters of primary esophageal adenocarcinoma samples as
compared with normal esophageal mucosa. In xenograft
models of tumorigenesis using esophageal
adenocarcinoma cells, inhibition of the Notch pathway via
treatment with a γ-secretase inhibitor greatly reduced
primary tumor growth.
 Notch may serve as a tumor suppressor in murine skin.
Deletion of Notch1 in the epidermis resulted in the
development of spontaneous BCC-like skin tumors.

44. Targeting signal cascades
 The Notch ligand, DLL4, has been another popular
targeting strategy in cancer. Treatment with anti-DLL4
monoclonal antibody results in disorganized angiogenesis
due to its effect on endothelial cells and in clinical trial
inhibition of DLL4 has demonstrated good safety and
preliminary efficacy
 Targeting STAT3 was shown to reduce glioblastoma brain
Tumor stem cells in pre-clinical models. WP1066, a STAT3
inhibitor, is currently in Phase 1 clinical trial from patients
with recurrent malignant glioma and brain metastasis from
melanoma
 The most clinically advanced Hh targeting therapy is
vismodegib, which is approved by the FDA for the
treatment of metastatic basal cell carcinoma

45. Targeting surface markers
 CD44 is the most common CSC marker and plays a
major role in enhancing stemness and communication
with the microenvironment . However Anti CD 44 is in
phase 1 clinical trail.
 Imatinib is a tyrosine kinase inhibitor that selectively
inhibits c-kit, BCR/ABL and PDG F receptors and is
approved for the treatment of chronic myelogenous
leukemia(CML) and unresectable CD117+
gastrointestinal stromal tumors